Unlike the β-cells that are affected in type 1 diabetes mellitus through autoimmunity, impairment of insulin secretion in T2DM occurs in a multifactorial, non-autoimmune process (Halban et al., 2014; Kawasaki, 2014). The gene discussed is INS; the disease is type 2 diabetes mellitus.